Search results
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
When the price of a high-quality stock such as AbbVie (NYSE: ABBV) declines after a report revealing growth, outperformance, and better-than-expected guidance, it's almost always a good time to
AbbVie Down Since Q4 Earnings Report: How to Play the Stock
AbbVie (ABBV) stock felt some downward pressure despite reporting better-than-expected fourth-quarter results on Feb. 4. AbbVie beat estimates for both earnings and sales and also issued an upbeat
Buy AbbVie Stock Before Q4 Earnings? Here's What to Know
AbbVie ABBV is set to report fourth-quarter and full-year 2025 earnings on Feb. 4, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $16.36
VWDRY or ABBNY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Manufacturing - Electronics sector might want to consider either Vestas Wind Systems AS (VWDRY) or ABB (ABBNY). But which of these two companies is the best
AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View
AbbVie Inc. ABBV reported fourth-quarter 2025 adjusted EPS of $2.71, which beat the Zacks Consensus Estimate of $2.66. The reported figure also exceeded the company’s guidance of $2.61-$2.65 issued
Here's What Will Drive AbbVie's Top-line Growth in 2026
AbbVie ABBV had an encouraging year in 2025, registering a sales growth of about 8.5% year over year at constant exchange rates. This number is impressive for a company that has been facing
Here's Why AbbVie (ABBV) is a Strong Value Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
ABB (ABBNY) Is Up 0.60% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
3 Reasons Why Growth Investors Shouldn't Overlook ABB (ABBNY)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Why AbbVie (ABBV) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Abbott Aktie: FDA-Rückruf
Abbott muss sich ausgerechnet bei einem seiner wichtigsten Wachstumstreiber erklären: Die US-Arzneimittelbehörde FDA meldet…
Der Beitrag Abbott Aktie: FDA-Rückruf erschien zuerst auf kapitalmarktexp
AbbVie Aktie: Marktumfeld beobachtet
AbbVie hat das vergangene Geschäftsjahr mit Rekordumsätzen abgeschlossen und sowohl beim Gewinn als auch…
Der Beitrag AbbVie Aktie: Marktumfeld beobachtet erschien zuerst auf kapitalmarktexperten.de
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of
Drone Delivery Canada Corp.
WKN: A3DP5Y / Name: Drone Delivery Canada / Stock / Metals & Mining / Micro Cap /
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for